Day 1 : Tuesday 6th Feb |
Room 1 - ARZANAH
|
|
| 08:00 10:00 |
|
| 10:00 10:30 |
Opening Ceremony
|
Session 1 Hepatitis B
|
Chairman: Prof. Abou El-Dahab El-Sahly
|
| 10:30 11:00 |
Hepatitis B in Middle East
Dr. Makki Fayadh, FRCP
|
| 11:00 11:30 |
The Treatment Challenges of Chronic Hepatitis B
Dr. Jose D. Sollano, MD
|
| 11:30 11:55 |
Treatment of Hepatitis B e-antigen Positive
Dr. Salem Awad, FRCP
|
| 11:55 12:25 |
Co- Infection HBV & HCV
Dr. Gamal Shiha, MD
|
| 12:25 12:55 |
Prevalence of Hepatitis B Antibodies in Healthcare Workers
In Yasuj/Iran Hospitals
Dr. Bahador Sarkari, PhD
|
| 12:55 13:20 |
|
| 13:20 14:30 |
Lunch Break
|
Session 2 Hepatitis C
|
Chairman: Dr. J. D. Sollano
|
| 14:30 14:55 |
Schistosomiasis and Hepatitis C in Egypt
Dr. Abou El-Dahab El-Sahly, MD
|
| 14:55 15:20 |
TT Virus and HCV Molecular Mimicry Antibody Response
In Chronic and Persistent Liver Diseases
Dr. Moslih I. Al-Moslih, MD
|
| 15:20 15:45 |
Retreatment of HCV patients Non Responders &
Relapsers with PegINF α - 2 b + Ribavirin
Dr. Frederik Nevens, PhD
|
| 15:45 16:05 |
Steatosis and Hepatitis C
Dr. Daniel Dhumeaux, PhD
|
| 16:05 16:30 |
HCV Genotyping for Treatment
Dr. William Rosenberg, PhD
|
| 16:30 16:45 |
Sustained Virological Response of PegINF α 2a +
Ribavirin
In HCV Genotype-4 Patients
Dr. Gamal Shiha, MD
|
| 16:45 17:00 |
|
Day 2 : Wednesday 7th Feb |
Room 1 - ARZANAH |
Session 3 Liver Transplant
|
Chairman: Dr. Christopher Record
|
| 08:00 08:25 |
Stem Cell Transplantation Using Autologous
Haematopoietic
Stem Cell Transplantation (CD 34)
Dr. Hosny Salama, MD
|
| 08:25 08:50 |
Liver Transplantation: Indications, Living Donations, Non-heart
Beating Donors (first clinical results)
Dr. Johan Fevery, PhD
|
| 08:50 09:15 |
HVB & Liver Transplantation
Dr. Gamal Esmat, MD
|
| 09:15 09:40 |
Liver Transplantation and Liver Surgery
Dr. Krister Hφckerstedt, PhD
|
| 09:40 10:00 |
Liver Surgery in UAE
Dr. Farouk Al Safi, PhD
|
| 10:00 10:20 |
|
| 10:20 10:50 |
|
Room 1 ARZANAH
|
Session 4 Hepatobiliary Diseases
|
Chairman: Dr. Johan Fevery
|
| 10:50 11:15 |
Hepatocellular Cancer Diagnosis and Treatment Options
Dr. Christopher Record, FRCP
|
| 11:15 11:40 |
Fever of Unknown Origin in Liver Diseases
Dr. Abou El-Dahab El- Sahly, MD
|
| 11:40 12:05 |
Hepatocellular Carcinoma & Cholangiocarcinoma
Dr. Johan Fevery, PhD
|
| 12:05 - 12: 20 |
Transhepatic Management of
Biliary Tract Diseases
Dr. Mazen Taha, MD
|
| 12:20 12:35 |
Radiofrequency Ablation of the Spleen for Ameliorating
Hypersplenism in Patients with Liver Cirrhosis and Portal
Hypertension, Clinical Study
Dr. Hosny Salama, MD
|
| 12:35 12:50 |
Acute Liver Failure in Children
Dr. Samia A. Mahmoud, MRCPCH
|
| 12:50 13:05 |
Gallbladder Daughter Hydatid Cyst Simulating GiantGallbladder Polyp
Dr. Abdulhakim Omer Al-Tamimi, MD
|
| 13:05 13:20 |
Session Discussion
|
| 13:20 14:30 |
Lunch Break
|
Room 1 ARZANAH
|
Session 5 Miscellaneous
|
Chairman: Dr. M. Al Ateek
|
| 14:30 14:55 |
Transjugular Intrahepatic Portosystemic Shunt (TIPS)
Current Usage and Recommendations
Dr. Christopher Record, FRCP
|
| 14:55 15:20 |
Improvement in Liver Histology after 3 years of HCV E1 Therapeutic Vaccination in Patients with
Chronic Hepatitis C
Dr. Frederik Nevens, PhD
|
| 15:20 15:45 |
Liver Diseases in Pregnancy
Dr. Daniel Dhumeaux, PhD
|
| 15:45 16:00 |
Thrombocytopenia in Chronic Liver Diseases
Dr. Mohamad Al Ateek, MD
|
| 16:00 16:30 |
The Enhanced Liver Fibrosis (ELF) Test Detects Fibrosis
and Predicts Liver Related Outcomes
Dr. William Rosenberg, PhD
|
| 16:30 17:00 |
Session Discussion
|
Room 2 OASIS
|
Session 6
|
Chairman: Dr. Dr. Gamal Shiha
|
| 10:30 11:00 |
The Role of LactoFerrin in Patients with
Chronic Hepatitis C Virus
Dr. Jean Paul, PhD
|
| 11:00 11:30 |
Modern Management of Auto Immune Hepatitis in Children
Dr. Ahmed Abdulla, MD
|
| 11:30 12:00 |
Autoimmune Diseases and Chronic Viral Hepatitis
Dr. Mohammed Al Aghbar, MD
|
| 12:00 12:30 |
Changes in Histology of Patients with Chronic HBV after
PegINF α 2a Treatment; an Immunohistochemical
Approach to Viral Antigen Expression & α SMA
Dr. Heba Yousef, MD
|
| 12:30 13:00 |
HCV; Co-Factors and Outcome
Dr. Aly El Sayed, MD
|
| 13:00 13:20 |
Session Discussion
|
| 13:20 14:30 |
Lunch Break
|
Session 7 Singapore Experience In Liver Transplant.
|
Chairman: Dr. Salem Awad
|
| 14:30 15:00 |
Management of Liver Failure
Dr. Lee Kang Hoe, MD
|
| 15:00 15:30 |
Evaluation of Transplant Candidate
Dr. Desmond Wai Chun Tao, MD
|
| 15:30 16:00 |
Adult Living Donor Liver Transplantation
Dr. Tan Kai Chah, MD
|
| 16:00 16:30 |
Management of the Post Liver Transplant
Dr. Desmond Wai Chun Tao, MD
|
| 16:30 17:00 |
Session Discussion
|
Day 3 : Thursday 8th Feb |
Room 1 - ARZANAH
|
Session 8 Non-Viral Liver Diseases
|
Chairman: Dr. Gamal Esmat
|
| 08:00 08:25 |
Acute Hepatitis Induced by Herbs
Dr. Makki Fayadh, FRCP
|
| 08:25 09:50 |
Diabetes Mellitus in Liver Diseases
Dr. Mohamad Al Ateek, MD
|
| 09:50 09:05 |
Neuropsychiatric Aspects of Hepatic Encephalopathy in
Drug Addicts
Dr. El Zein Omara, FRCP PSY
|
| 09:05 09:20 |
The Liver and Anti-phospholipid Syndrome
Dr. Tamer Adham, MD Paediatrics
|
| 09:20 09:45 |
Session Discussion
|
| 09:45 10:15 |
Break
|
Session 9 Liver Cirrhosis
|
Chairman: Dr. Daniel Dhumeaux
|
| 10:50 11:10 |
Minimal Encephalopathy - Diagnosis & Assessment
Dr. Hanan Mardini, MD
|
| 11:10 11:30 |
Acute Hepatic Failure
Dr. Tawheed Mowafi, MD
|
| 11:30 11:50 |
Treatment of Hepatitis C Genotype-4
Dr. Gamal Esmat, MD
|
| 11:50 12:10 |
Surgery in Patients with Liver Diseases
Dr. Wael Dahnan, MD
|
| 12:10 12:25 |
Session Discussion
|
Session 10 Panel Discussions A&B
|
12:25 13:25 A: Hepatitis B Management
|
| Chairperson |
Dr. Abou El-Dahab El-Sahly, PhD
|
| Moderator |
Dr. Aly El-Sayed, MD
|
| Panel Members |
Dr. J. D. Sollano, MD
Dr. Hosny Salama, MD
Dr. Christopher Record, PhD
Dr. Amin Al Amiri, MD
|
| Key Invitees |
General Authority of Health Services of Abu Dhabi
Ministry of Health Department of Health and Medical
Services Department of Preventive Medicine, Abu Dhabi
|
| 13:25 14:30 |
Lunch Break
|
14:30 15:30 B: Hepatitis C Management
|
| Chairperson |
Dr. Johan Fevery, PhD
|
| Moderator |
Dr. Salem Awad, FRCP
|
| Panel Members |
Dr. Daniel Dhumeaux, PhD
Dr. Gamal Shiha, MD
Dr. Frederik Nevens, PhD
Dr. Abdulla Al Toum, FRCP
|
| Key Invitees |
General Authority of Health Services of Abu Dhabi
Ministry of Health, Abu Dhabi
Department of Health and Medical Services
Department of Preventive Medicine, Abu Dhabi
|
| 15:30 16:00 |
Conference Highlights & Closing Remarks
|
Room 2 - OASIS
|
Session 11 |
Chairman: Dr. Gamal Shiha |
| 10:00 10:30 |
Hepato-Renal Syndrome
Dr. Mohammad Sharaf El Din, MD
|
| 10:30 11:00 |
Immune Mediated Liver Disorders
Dr. Ahmed Abdul Samie, MD
|
| 11:00 11:30 |
Liver Cirrhosis in Jordan
Dr. Mohammed Hilwah, MD
|
| 11:30 12:00 |
Hepatitis B Knowledge and practice among
Iranian Men & Women
Dr. Amir Tabatabayee, PhD
|
| 12:00 12:30 |
Imaging Liver Diagnosis
Dr. Ehtuish Faraj Ehtuish, PhD
|
12:30 13:00 |
Liver Diseases in Central Asia
Dr. Shokrat, PhD |
16:00 16:30 Closing Ceremony |
